Cargando…

Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences

INTRODUCTION: National competent authorities (NCAs) for medicines coordinate communication relating to the safety of medicines in Europe. The effectiveness of current communication practices has been questioned, particularly with regard to reaching general practitioners (GPs). OBJECTIVE: The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Sieta T., van der Sar, Maartje J. M., Cupelli, Amelia, Baldelli, Ilaria, Coleman, Anna Marie, Montero, Dolores, Šipić, Ivana, Andrić, Adriana, Wennberg, Annika, Ahlqvist-Rastad, Jane, Denig, Petra, Mol, Peter G. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519651/ https://www.ncbi.nlm.nih.gov/pubmed/28540672 http://dx.doi.org/10.1007/s40264-017-0535-0

Ejemplares similares

Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2018)

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
por: de Vries, Sieta T., et al.
Publicado: (2021)

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2020)

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care
por: Denig, Petra, et al.
Publicado: (2019)

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
por: de Vries, Esther, et al.
Publicado: (2020)

Trends in HbA(1c) thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients
por: Ambrož, Martina, et al.
Publicado: (2020)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020
por: Ambrož, Martina, et al.
Publicado: (2022)

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
por: de Vries, Sieta T., et al.
Publicado: (2018)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Changes in blood pressure thresholds for initiating antihypertensive medication in patients with diabetes: a repeated cross-sectional study focusing on the impact of age and frailty
por: Ambrož, Martina, et al.
Publicado: (2020)

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study
por: de Vries, Sieta T, et al.
Publicado: (2014)

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care
por: Ambrož, Martina, et al.
Publicado: (2022)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

The Role of Patients’ Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes
por: de Vries, Sieta T., et al.
Publicado: (2015)

Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
por: Ambrož, Martina, et al.
Publicado: (2021)

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study
por: Roldan Munoz, Sonia, et al.
Publicado: (2020)

Breast cancer awareness's and attitude among regular health-care users versus irregular in a sample of Kurdish women in the West of Iran
por: Rastad, Zahra, et al.
Publicado: (2021)

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study
por: de Vries, Sieta T., et al.
Publicado: (2016)

Awareness of General Practitioners toward Hypertension Management
por: Rawat, Ramakant, et al.
Publicado: (2021)

Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe
por: Sainz, Ángel, et al.
Publicado: (2015)

Veterinary pharmacovigilance in Europe: a survey of veterinary practitioners
por: De Briyne, Nancy, et al.
Publicado: (2017)

Use and Awareness of Heated Tobacco Products in Europe
por: Gallus, Silvano, et al.
Publicado: (2022)

Awareness of basic life support among dental practitioners
por: Baduni, Neha, et al.
Publicado: (2014)

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands
por: de Vries, Esther, et al.
Publicado: (2022)

Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study
por: AB, Elisabeth, et al.
Publicado: (2009)

Crimmigration in Europe
por: van der Woude, Maartje, et al.
Publicado: (2017)

Mathematical practitioners and the transformation of natural knowledge in early modern Europe
por: Cormack, Lesley B, et al.
Publicado: (2017)

Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2021)

Attention for sex in COVID-19 trials: a review of regulatory dossiers
por: de Vries, Sieta T, et al.
Publicado: (2022)

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2023)

Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe
por: Kallio, Marko J., et al.
Publicado: (2022)

Esthetic Indication for Dental Implant Treatment and Immediate Loading (3). Case Report and Considerations Regarding the Aspect of the Patient's Right to Self-Determination in Medical Decision-Making
por: Ihde, Stefan, et al.
Publicado: (2020)

Dental Implant Treatment and Immediate Functional Loading (1). Case Report and Considerations: Extended Treatment Options Using the Strategic Implant® and Indications and Objectives for Comprehensive Dental Implant Treatment
por: Ihde, Stefan, et al.
Publicado: (2019)

Functional and Esthetic Indication for Dental Implant Treatment and Immediate Loading (2) Case Report and Considerations: Typical Attitudes of Dentists (and their Unions) toward Tooth Extractions and the Prevention of Early, Effective, and Helpful Dental Implant Treatment in the European Union
por: Ihde, Stefan, et al.
Publicado: (2019)

Hepatitis B Vaccination and Screening Awareness in Primary Care Practitioners
por: Said, Adnan, et al.
Publicado: (2014)

Pseudorabies in pig industry of China: Epidemiology in pigs and practitioner awareness
por: Tan, Lei, et al.
Publicado: (2022)

Investigation on Awareness of Cognitive Impairment Diseases Among Surgical Practitioners
por: Hao, Yanan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4urhtli9kbk4nov3j2l22chnug